Literature DB >> 31254180

Complex therapies for advanced Parkinson's disease: what is the role of doctor-patient communication?

Elisa Montanaro1, Carlo Alberto Artusi2, Maurizio Zibetti2, Leonardo Lopiano2.   

Abstract

OBJECTIVES: Communication processes play a key role in the patient-doctor relationship. Few studies have considered communicative processes in advanced Parkinson's disease (PD), and in particular in the phase of proposing complex therapies (CT). Therefore, we explored the role of communication and patient-doctor relationship in the transition phase to CT for advanced PD, analysing satisfaction, factors influencing the relationship and patients' unmet needs.
MATERIALS AND METHODS: Twenty-four PD patients (mean age 61.7 ± 8.8 years; mean disease duration 12 ± 4.8 years) eligible for deep brain stimulation or infusion therapies were submitted to a semi-structured interview aimed to investigate communication-related cognitions, feelings and behaviours concerning PD and the possible transition towards CT. The Patient-Doctor Relationship Questionnaire (PDRQ-9) was administered along with neuropsychological and behavioural screening tests.
RESULTS: All patients discussed the possible transition to CT with a neurologist. A high degree of satisfaction about the relationship with the neurologist was revealed (mean PDRQ-9 score 37.3 ± 7.3). The communication not only aroused feelings of fear (11/24 patients) and concern (15/24 patients), but also fostered the hope for motor improvement (15/24 patients). Half the patients (12/24) wanted to receive more information about CT after communication.
CONCLUSIONS: This pilot study highlights the importance of doctor-patient communication in PD when facing the transition to CT. Trust in the physician emerged as a key point in favour of the therapeutic alliance. Neurologists should carefully consider patients' reactions and preferences for eliciting collaboration and treatment adherence, favouring a patient-centred standard of care.

Entities:  

Keywords:  Advanced phase; Communication; Deep brain stimulation; Infusion therapies; Parkinson’s disease; Therapies

Mesh:

Substances:

Year:  2019        PMID: 31254180     DOI: 10.1007/s10072-019-03982-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  31 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

3.  Patients' reluctance to undergo deep brain stimulation for Parkinson's disease.

Authors:  Mi-Ryoung Kim; Ji Young Yun; Beomseok Jeon; Yong Hoon Lim; Kyung Ran Kim; Hui-Jun Yang; Sun Ha Paek
Journal:  Parkinsonism Relat Disord       Date:  2015-11-19       Impact factor: 4.891

Review 4.  Theory of mind and neurodevelopmental disorders of childhood.

Authors:  Baris Korkmaz
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

5.  Levodopa and the progression of Parkinson's disease.

Authors:  Stanley Fahn; David Oakes; Ira Shoulson; Karl Kieburtz; Alice Rudolph; Anthony Lang; C Warren Olanow; Caroline Tanner; Kenneth Marek
Journal:  N Engl J Med       Date:  2004-12-09       Impact factor: 91.245

Review 6.  Treating the Motor Symptoms of Parkinson Disease.

Authors:  John C Morgan; Susan H Fox
Journal:  Continuum (Minneap Minn)       Date:  2016-08

Review 7.  The clinical progression of Parkinson's disease.

Authors:  Werner Poewe; Philipp Mahlknecht
Journal:  Parkinsonism Relat Disord       Date:  2009-12       Impact factor: 4.891

Review 8.  Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review.

Authors:  Karin Wirdefeldt; Per Odin; Dag Nyholm
Journal:  CNS Drugs       Date:  2016-05       Impact factor: 5.749

9.  The decision-making process leading to deep brain stimulation in men and women with parkinson's disease - an interview study.

Authors:  Katarina Hamberg; Gun-Marie Hariz
Journal:  BMC Neurol       Date:  2014-04-25       Impact factor: 2.474

Review 10.  Treatment of Parkinson's disease in the advanced stage.

Authors:  C Ossig; H Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2013-03-10       Impact factor: 3.575

View more
  2 in total

1.  Independence of Coping Styles With the Patient-Doctor Relationship and Shared Decision-Making in People With Parkinson's Disease.

Authors:  Cynthia Sarabia-Tapia; Teresa Corona; Susana Lopez-Alamillo; Etienne Resendiz-Henriquez; Amin Cervantes-Arriaga; Mayela Rodríguez-Violante
Journal:  J Patient Exp       Date:  2020-04-13

2.  Criteria for identification of advanced Parkinson's disease: the results of the Italian subgroup of OBSERVE-PD observational study.

Authors:  Alessandro Stefani; Alessandro Tessitore; Nicola Tambasco; Giovanni Cossu; Maria Gabriella Ceravolo; Giovanni Defazio; Francesca Morgante; Silvia Ramat; Gabriella Melzi; Giuliana Gualberti; Rocco Merolla; Koray Onuk; Leonardo Lopiano
Journal:  BMC Neurol       Date:  2022-01-28       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.